SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Holding(s) in Company

14 Nov 2014 14:23

RNS Number : 1036X
Consort Medical PLC
14 November 2014
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

 

Consort Medical Plc

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached.

 

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

Yes

 

Other (please specify):

 

3. Full name of person(s) subject to thenotification obligation:

Legal & General Group Plc (L&G)

4. Full name of shareholder(s)  (if different from 3.):

N/A

 

5. Date of the transaction and date onwhich the threshold is crossed orreached:

 

12 November 2014

6. Date on which issuer notified:

14 November 2014

7. Threshold(s) that is/are crossed orreached:

 

L&G (Below 3%)

 

8. Notified details:

 

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

 

Numberof shares

Number of votingrights

% of voting rights

Direct

Indirect

Direct

Indirect

ORD GBP 0.10

 882,665

 

(As on 25/06/2014)

Below 3%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

 

Expirationdate

 

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

 

 

Exercise price

 

Expiration date

 

Exercise/Conversion period

 

Number of voting rights instrument refers to

 

 

% of voting rights

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

Below 3%

 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

Legal & General Group Plc (Direct and Indirect) (Group)

Legal & General Investment Management (Holdings) Limited (LGIMH) (Direct and Indirect)

Legal & General Investment Management Limited (Indirect) (LGIM)

Legal & General Group Plc (Direct) (L&G) (Below 3% = LGAS, LGPL & PMC)

Legal & General Investment Management (Holdings) Limited (Direct) (LGIMHD)

Legal & General Insurance Holdings Limited (Direct) (LGIH)

Legal & General Assurance (Pensions Management) Limited (PMC)

Legal & General Assurance Society Limited (LGAS & LGPL)

Legal & General Pensions Limited (Direct) (LGPL)

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

Notification using the total voting rights figure of 49,072,324

 

14. Contact name:

Angela Hayter (LGIM)

15. Contact telephone number:

020 3124 3851

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBIBITMBBBBPI
Date   Source Headline
8th Apr 20159:57 amRNSDirector Declaration
1st Apr 20159:07 amRNSTotal Voting Rights
23rd Mar 20152:44 pmRNSHolding(s) in Company
12th Mar 20152:53 pmRNSHolding(s) in Company - Replacement
11th Mar 20159:10 amRNSHolding(s) in Company
23rd Feb 20157:00 amRNSVoke® licence - variation granted by MHRA
11th Feb 201511:12 amRNSDirectorate Change
4th Feb 20157:00 amRNSIntegrated Dose Counter Supply Agreement
3rd Feb 201511:37 amRNSHolding(s) in Company
2nd Feb 20159:43 amRNSTotal Voting Rights
29th Jan 20157:00 amRNS£2.2m investment in Atlas Genetics Series C
26th Jan 201512:47 pmRNSDirector/PDMR Shareholding
6th Jan 20153:48 pmRNSDirector/PDMR Shareholding
5th Jan 20152:46 pmRNSTotal Voting Rights
9th Dec 201410:37 amRNSDirector/PDMR Shareholding
4th Dec 20147:00 amRNSHalf Yearly Report
2nd Dec 20141:43 pmRNSBlocklisting Interim Review
28th Nov 201411:31 amBUSForm 8.3 - CSR PLC - Replacement
27th Nov 20142:53 pmBUSForm 8.3 - CSR PLC
27th Nov 20149:00 amRNSHolding(s) in Company
14th Nov 20142:23 pmRNSHolding(s) in Company
12th Nov 201411:09 amRNSAcquisition of Aesica Holdco Limited
12th Nov 201410:06 amRNSTotal Voting Rights
7th Nov 201410:23 amRNSHolding(s) in Company
6th Nov 201412:58 pmRNSHolding(s) in Company
5th Nov 201412:26 pmRNSAdditional Listing
5th Nov 201410:04 amRNSHolding(s) in Company
4th Nov 201412:45 pmRNSTotal Voting Rights
4th Nov 201412:36 pmRNSDirector/PDMR Shareholding
3rd Nov 20149:35 amRNSResults of Rump Placing
3rd Nov 20147:00 amRNSResults of Rights Issue
29th Oct 20144:51 pmRNSDirector/PDMR Shareholding
28th Oct 20145:02 pmRNSHolding(s) in Company
22nd Oct 20147:00 amRNSDevelopment Contract Award
21st Oct 20142:28 pmRNSGerman anti-trust clearance
17th Oct 20148:02 amRNSADMISSION OF NEW ORDINARY SHARES
16th Oct 201412:00 pmRNSResult of EGM
15th Oct 20141:30 pmRNSBlocklisting Interim Review
6th Oct 201410:19 amRNSDirector/PDMR Shareholding
2nd Oct 20141:55 pmRNSHolding(s) in Company
1st Oct 201411:47 amRNSTotal Voting Rights
30th Sep 20143:44 pmRNSPublication of Prospectus
30th Sep 20147:00 amRNSProposed acquisition of Aesica Holdco Limited
12th Sep 20147:00 amRNSMHRA Authorisation of the Voke Inhaler
5th Sep 20143:06 pmRNSHolding(s) in Company
4th Sep 20143:28 pmRNSResult of AGM
4th Sep 20147:00 amRNSInterim Management Statement
29th Jul 20144:28 pmRNSDirector/PDMR Shareholding
29th Jul 201412:10 pmRNSAnnual Financial Report
25th Jul 201410:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.